You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昂利康(002940.SZ):擬以2億元受讓新合新18.19%股權
格隆匯 01-28 20:52

格隆匯1月28日丨昂利康(002940.SZ)公佈,公司於2022年1月28日召開第三屆董事會第十次會議,審議通過了《關於受讓湖南新合新生物醫藥有限公司部分股權暨對外投資的議案》,同意公司以自有或自籌資金2億元人民幣受讓廣東溢多利生物科技股份有限公司(簡稱“溢多利”)持有的湖南新合新生物醫藥有限公司(“新合新”或“標的公司”或“目標公司”)部分股權。

公司與其他交易購買方合計以現金8.22億元受讓標的公司74.8057%股權,其中公司以自有或自籌資金2億元受讓標的公司18.19%股權,受讓價格為41.60元/單位註冊資本。

同時,標的公司為收購湖南科益新生物醫藥有限公司(“科益新”或“湖南科益新”,根據溢多利與新合新簽署的關於《科益新股權轉讓協議》,約定本次科益新100%股權轉讓的價格為5000萬元人民幣)及清償新合新和科益新對溢多利的債務,同意由增資方對標的公司進行增資,增資價格為41.60元/單位註冊資本,其中1259.6152萬元計入新合新註冊資本,5.114億元計入新合新資本公積金。

上述交易中,收購資產、增資與清償債務互為條件,交易全部完成後,公司將持有新合新12.32%股份。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account